PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years
- 1 September 1995
- journal article
- clinical trial
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 76 (3) , S228-S232
- https://doi.org/10.1016/s0090-1229(95)90306-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Four new adenosine deaminase mutations, altering a zinc-binding histidine, two conserved alanines, and a 5′ splice siteHuman Mutation, 1995
- Heterogeneity of phenotype in two siblings with adenosine deaminase deficiencyJournal of Allergy and Clinical Immunology, 1994
- Severe Combined Immunodeficiency of Reduced Severity Due to Homozygosity for an Adenosine Deaminase Missense Mutation (ARG253PRO)Cellular Immunology, 1993
- Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.Journal of Clinical Investigation, 1993
- Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patientsThe Journal of Pediatrics, 1993
- T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.Journal of Clinical Investigation, 1993
- Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiencyEuropean Journal of Pediatrics, 1992
- European experience of bone-marrow transplantation for severe combined immunodeficiencyThe Lancet, 1990
- Adenosine deaminase deficiency with late onset of recurrent infections: Response to treatment with polyethylene glycol-modified adenosine deaminaseThe Journal of Pediatrics, 1988
- Treatment of Adenosine Deaminase Deficiency with Polyethylene Glycol–Modified Adenosine DeaminaseNew England Journal of Medicine, 1987